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Abstract
On their own, antibacterial agents cannot cure an infectious disease. They need 
help from the innate immune response followed by the adaptive immune response 
and inflammatory response. An overview of Toll-Like Receptors (TLR) as key players 
in the innate immune response is given followed by a review of published results 
obtained in the authors laboratory related to the effect of several antibacterial 
agents on the action of bacterial lipopolysaccharide (LPS), a ligand for TLR-4. 
The results indicated that the antibacterial agents tested were anti-inflammatory. 
Inflammation is a two edged sword; in moderation it is beneficial, but deleterious 
if in excess. It is suggested that infectious disease specialists monitor serum pro-
inflammatory cytokine and/or nitric oxide levels of their patients on antibacterial 
therapy and when needed, treat with a cytokine, a TLR agonist or a TLR antagonist 
where indicated.
 
Antibacterial agents on their own are not capable of eradicating infections ef-
ficiently. Help coming from the patient’s innate immune response followed by the 
adaptive immune response and inflammatory response is needed. This has been 
observed in patients with immunodeficiency diseases such as X-Linked Agam-
maglobulinemia, Chronic Granulomatous Disease and CD40 Ligand Deficiency (1). 
Treatment of these patients with antibacterial agents might temporarily control the 
infection. However, recurrences’ always occur.
This article is available from: 
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 One of the major players in the innate immune response is 
the Toll-Like Receptors (TLR). Toll Receptors were first dis-
covered in the fruit fly, Drosophilia melanogaster (2). Their 
human homologues were discovered soon after and were 
called Toll-Like Receptors (3).
Toll-Like Receptors (TLR) are expressed by a number of cell 
types including dendritic cells and macrophages. So far 13 
TLRs have been identified (TLR-1 to 13). Some are expressed 
on the cell surface (TLR-1, 2, 4, 5, 6, 10, 11, 12) others are 
expressed on the cell endosome (TLR-3, 7, 8, 9, 13). Not all 
TLR are necessarily expressed by the same cell (4). TLR belong 
to a group of receptors called Pattern Recognition Receptors 
(PRR). They are called so because they serve as receptors 
for conserved molecular patterns found in infectious agents. 
These patterns serve as ligands for TLR. The ligands are called 
Pathogen Associated Molecular Patterns (PAMPS) (5, 6). Li-
gands and their receptors are given in Table 1.
What happens when a ligand engages its receptor? One or 2 
signal pathways are activated; the MyD88 dependent and the 
MyD88 independent pathways. These results in the activation 
of the nuclear factors Nf-Kb, IRF-3 and/or IRF-7 that enter the 
nucleus and promote the transcription of genes that code for 
the production of cytokines needed for the generation of the 
adaptive immune response and inflammatory response. Some 
of the cytokines produced are IL-1 beta, TNF, IL-4, IL-6, IL-8, 
IL-12, and alfa and beta interferon (7,8) This is schematically 
shown in Figure 1 (9) and the functions of the cytokine 
produced are given in Table 2.
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In addition, it has been reported that nitric oxide is generated 
when LPS engages TLR-4 and can be considered as a marker 
for inflammation. Panaro et al. (10) reported that TLR-4 medi-
ated LPS-induced release of nitric oxide and TNF-α by chick 
embryonal cardiomyocytes. He et al. (11) compared a number 
of TLR ligands in their ability to induce the production of ni-
tric oxide by chick monocytes and reported that LPS (ligand 
for TLR-4) and CpG ODN (ligand for TLR-9) were the most 
potent inducers.
LPS and cytokines produced induce macrophages, hepato-
cytes, vascular smooth muscle and cardiacmyocytes to pro-
duce nitric oxide . Nitric oxide is produced when L-arginine is 
converted to L-citrulline. The enzyme needed for this conver-
sion is nitric oxide oxidase that exists in 3 different isoforms, 
namely, neuronal, endothelial and inducible nitric oxide syn-
thetase. Nitric oxide is involved in killing invading infectious 
agents. (12) 
Toll-Like Receptors and the generation of nitric 
oxide. 
Considering the production of nitric oxide as a marker for 
inflammation we studied the effects of gentamicin, tobramy-
cin, imipenem, tigecycline and isoniazid on serum physiologi-
cal levels of nitric oxide and levels induced by LPS in mice. All 
5 antibacterial agents reduced serum physiological levels and 
levels induced by LPS of nitric oxide in mice (13,14),
Table 1. TLR and their ligands.
TLR                Ligands
1+2 bacterial lipoproteins
2+6 bacterial lipoproteins, lipoteichoic acid, mannans
3 dsRNA




9 unmethylated CpG bacterial DNA
10 unknown
11 profilin (Toxoplasma gondii)
12 unknown
13 23S ribosomal RNA
With the exception of gentamicin and tobramycin, the anti-
bacterial agents tested had different mechanisms of antibac-
terial action, yet they all suppressed nitric oxide production. 
Hence it can be speculated that the 5 antibacterial agents 
tested are anti-inflammatory agents. 
Effect of vancomycin and tobramycin on the 
production of cytokines
At about the same time that human TLR were discovered 
(3) we reported that vancomycin and tobramycin suppressed 
the levels of TNF-α and gamma-interferon induced by LPS 
(15). It has been mentioned earlier that TNF-α and IL-12 are 
cytokines produced upon the engagement of LPS with TLR-4. 
IL-12 is needed for the activation of Th1 lymphocytes. Once 
activated Th1 lymphocytes will produce gamma-interferon. 
Later, we studied the effect of two TLR ligands, LPS and 
bacterial DNA on the production of IL-1β, IL-10 and IL-12 by 
mouse peritoneal macrophages in vitro. The levels of all 3 
cytokines were elevated when macrophages were treated 
with either LPS or bacterial DNA. However, the potency of 
the two TLR ligands differed. LPS was more potent in induc-
ing the production of IL-1β and IL-12 and bacterial DNA was 
more potent in inducing the production of IL-10 (16). From 
these 2 studies it can be suggested that vancomycin and 
tobramycin interfered with the LPS- TLR-4 signaling result-
ing in suppressed production of cytokines and thus can be 
considered anti-inflammatory agents.
Modified bacterial ligands and TLR
An interesting article recently appeared in Science that dealt 
with 23S rRNA and TLR-13 (53). They reported that the li-
gand for TLR-13 is the 23S rRNA. Additionally, they showed 
that the methylated 23S ribosomal RNA, isolated from eryth-
romycin-resistant Staphylococcus aureus failed to stimulate 
TLR-13. The target site for lincosamide, streptogamins and 
erythromycin is the 23S ribosomal RNA. These antibacterial 
agents bind to it and inhibit bacterial protein synthesis. The 
primary means of resistance to these antibacterial agents is 
by post-transcriptional methylation of 23S ribosomal RNA. 
So we have the 23S ribosomal RNA as a target site for the 
antibacterial agents and are a ligand for TLR-13. It can be as-
sumed that the methylated form was not capable of inducing 
the production of cytokines, and adaptive immunity and the 
inflammatory response were suppressed. There are questions 
that need to be answered with respect to the Odenburg et 
al. report (5). Such as, will other ligand-TLR interactions com-
pensate for this defect? Will other innate immune responses 
such as activation of the complement system be affected by 
resistant strains?
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Table 2. Some properties of cytokines that are generated.
Cytokine Properties
IL-1
mediator of acute inflammation. Stimulates endothelial cells to produce adhesion 
molecules and chemokines, produces fever, promotes production of acute phase 
reactants, helps in activating T-lymphocytes. 
TNF-α 
mediator of acute inflammation. Stimulates endothelial cells to produce adhesion 
molecules and chemokines, produces fever, promotes production of acute phase 
reactants, 
 IL-4 stimulates development of Th2 lymphocytes, stimulates immunoglobulin class switching to the IgE isotype.
IL-6 stimulates production of acute phase reactants
IL-8 attracts (chemokine) and activates neutrophils
IL-12 stimulates production of ϒ-interferon, promotes production of Th1 lymphocytes, enhances cytototoxic effect of T-cytotoxic and NK cells
α and β interferon antiviral agents
Figure 1. Ligand-TLR engagement 
and signaling pathways leading to the 
production of cytokines
* Taken from MacKichan ML (9). Modified to include TLR 13.
Is the production of cytokines and nitric oxide 
in the innate immune response beneficial or 
harmful?
It appears that some antibacterial agents suppress the pro-
duction of pro-inflammatory cytokines and nitric oxide by 
interfering with ligand-TLR interactions and their signaling 
pathways. Moreover, methylated 23S rRNA was reported to 
be unable to activate TLR-13. Production of pro-inflammatory 
cytokines and nitric oxide in physiological amounts would 
be an aid to antibacterial agents in controlling an infection. 
The inability to produce pro-inflammatory cytokines could 
lead to recurrent, invasive pyogenic infections. This is seen 
in Inherited Human IRAK-4 deficiency. IRAK-4 is an inter-
mediate in the ligand-TLR signaling pathway leading to the 
production of pro-inflammatory cytokines. A defect in the 
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gene that codes for IRAK-4 will block the signaling pathway 
(17). On the other hand, excessive production of pro-inflam-
matory cytokines and nitric oxide can be deleterious. Toxic 
Shock Syndrome that often results in multi-organ failure is 
due to excessive production of cytokines. Certain strains of 
Staphylococcus aureus and Streptococcus pyogenes produce 
toxins that behave as superantigens. They activate both an-
tigen presenting cells and T-lymphocytes causing these cells 
to produce excessive amounts of cytokines. (18). In addition, 
uncontrolled production of pro-inflammatory cytokines, in 
particular IL-1β is seen in Hereditary Periodic Fever. These 
patients suffer from recurrent episodes of fever that may or 
may not be accompanied by infection (19). 
Nitric oxide on one hand is involved in killing microorgan-
isms and on the other hand excess production is thought to 
contribute to hypotension and septic shock (12).
Perhaps it would be advisable that infectious disease special-
ists monitor serum cytokine and/or nitric oxide levels of their 
patients on antibacterial therapy and consider using a cyto-
kine, TLR agonist or TLR antagonist where indicated (5). In the 
case of excess production of nitric oxide, the use of 1400W, 
an inhibitor of inducible nitric oxide can be considered if this 
drug is FDA-approved (20, 21).
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